Thermogenesis Holdings Inc (THMO) said after close Monday that it lost $1.09 per share in quarter three 2023. The company reported earnings on an adjusted basis, so it may not be directly comparable to analyst estimates or prior periods.
On the revenue line, the company reported $2.2 million, missing estimates by $906 thousand.
In the same quarter a year ago, the company lost $4.5 per share on revenue of $2.1 million.
The stock is down 15.70% to $1.02 after the report.
The firm's lower revenue growth to earnings signals that the firm has been able to reduce costs and improve its profit margin overall.
Wall Street Analysts had an average rating of Strong Buy on the stock prior to the report.
Trading in the five days leading up to the report earned Thermogenesis Holdings Inc a Bullish Sentiment Rank from InvestorsObserver.
Thermogenesis Holdings Inc has performed a little below average during the past few months. Before the report, Thermogenesis Holdings Inc received a Long-Term Technical Rank by InvestorsObserver of 35, putting it in the bottom half of stocks. The firm was recently trading at a 52-week low of $0.9 on November 1, 2023 and set a 52-week high on November 30, 2022 at $6.75.
ThermoGenesis Holdings Inc. develops commercializes and markets a range of automated technologies for CAR-T and other cell-based therapies. The Company currently markets a full suite of solutions for automated clinical biobanking point-of-care applications and automation for immuno-oncology including its semi-automated functionally-closed CAR-TXpress platform which streamlines the manufacturing process for the emerging CAR-T immunotherapy market.
News Home
Thermogenesis Holdings Inc Down 15.70% To $1.02 After Earnings Miss
Mentioned in this article
